We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

26 Sep 2023 - 28 Sep 2023
26 Sep 2023 - 28 Sep 2023

World’s First Digital Human Organism Introduced at MEDICA 2021

By Dan Gueron, Publisher
Posted on 16 Nov 2021
Print article
Image: AIBODY platform (Photo courtesy of AIBODY.IO LTD.)
Image: AIBODY platform (Photo courtesy of AIBODY.IO LTD.)

AIBODY.IO LTD. (London, UK) unveiled the world's first complete digital human organism which can simulate virtually any medical condition or treatment at MEDICA 2021.

The AIBODY platform can produce true-to-life, highly detailed physiological responses to virtually any simulated medical condition or treatment protocol. Rather than rely on mathematical models to mimic aspects of human physiology, AIBODY’s virtual patient software is modeled from the sub-cellular level up and incorporates 132,000 parameters that interact to create lifelike simulations of interrelated biophysical, physiological, and biochemical processes occurring within a human body. AIBODY’s core product realistically replicates all concurrent cardiovascular, pulmonary, and bleeding processes, with other organ systems available soon.

AIBODY’s user-friendly interface, enhanced 3D graphics, and unlimited opportunities for customization and collaboration are revolutionizing medical education and training. The cloud-based AIBODY platform offers a dynamic virtual learning environment in which teams can diagnose and treat a broad range of medical conditions without risk to live patients or the need for physical presence. The AIBODY AR solution introduces sophisticated gesture controls and intuitive layouts that enable team-wide immersive experiences for multiple, geographically dispersed users collaborating on practical simulation exercises.

“Our medical simulation software lets us observe and treat a true-to-life digital patient – in real time and from anywhere in the world,” said AIBODY CEO Richard Littlehales. “It responds to injury and treatment exactly as a real human organism would, leading to myriad potential uses in medical education, professional certification training, bespoke simulations of medical procedures, and AR blended with haptics. In the future, we envision expanding the use of our platform to assist with clinical decision support, patient engagement, and pharmaceutical R&D and clinical trials.”

“COVID-19 has exposed systemic vulnerabilities in medical education and training that AIBODY is well positioned to solve,” added Littlehales. “Ours is the first platform to combine a unique human physiology engine with state-of-the-art visualization technologies, creating a product that requires minimal setup and enables the running of industry-leading simulations within minutes. Projects we are already working on include bringing textbooks to life through real-time patient simulation exercises that test students’ theoretical knowledge, and building customized ‘flight simulators’ for doctors and medical device developers to practice actual treatment routines.”

Related Links:
AIBODY.IO LTD.

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Supplier
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
PACS Workstation
CHILI WebViewer NG
New
Volumetric Infusion Pump
CODAN A717V Plus/A718V Plus

Print article
Radcal

Channels

Critical Care

view channel
Image: Flexible thin-film electrodes placed directly on brain tissue have shown promise for diagnosis and treatment of epilepsy (Photo courtesy of Tokyo Tech)

Thin-Film Neural Electrodes Placed Directly on Brain Tissue Can Diagnose and Treat Epilepsy

Analyzing brain activity is crucial for diagnosing conditions like epilepsy and other mental health disorders. Among various methods, electroencephalography (EEG) is considered the least intrusive, using... Read more

Surgical Techniques

view channel
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)

AI Robotic System Selectively Kills Microscopic Tumor Cells without Damaging Surrounding Tissue

When treating cancer, surgeons usually aim to remove the tumor along with a surrounding "margin" of healthy tissue to make sure all cancer cells have been taken out. However, even with advancements in... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.